Modelling the Omicron wave in France in early 2022: Balancing herd immunity with protecting the most vulnerable

Article Virology

Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark

Kimihito Ito et al.

Summary: The Omicron variant of SARS-CoV-2 has spread rapidly across the globe, with 758 confirmed cases in Denmark. Based on Danish data, the effective reproduction number of Omicron is estimated to be 3.19 times higher than that of the Delta variant. It is expected that by December 28, 2021, over 95% of SARS-CoV-2 infections in Denmark will be caused by the Omicron variant.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

No further delays in offering booster doses in countries experiencing a major resurgence of COVID-19

Benjamin Davido et al.

JOURNAL OF TRAVEL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Hiam Chemaitelly et al.

Summary: In a study conducted in Qatar involving over 900,000 participants, vaccine effectiveness peaked at 77.5% in the first month after the second dose. However, it declined afterwards to as low as 20% in months 5 through 7 after vaccination, while protection against severe Covid-19 remained above 90% for at least 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

News Item Critical Care Medicine

The race between vaccination and evolution of COVID-19 variants

Talha Khan Burki

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar-On et al.

Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak

A. Wilder-Smith et al.

JOURNAL OF TRAVEL MEDICINE (2020)

Add to Collection

Modelling the Omicron wave in France in early 2022: Balancing herd immunity with protecting the most vulnerable

Related references

Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark

No further delays in offering booster doses in countries experiencing a major resurgence of COVID-19

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

The race between vaccination and evolution of COVID-19 variants

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak

Export Citation

Share Paper